RIMA M SALIBA to Antibodies, Monoclonal, Humanized
This is a "connection" page, showing publications RIMA M SALIBA has written about Antibodies, Monoclonal, Humanized.
Connection Strength
0.027
-
Vedolizumab for Steroid Refractory Lower Gastrointestinal Tract Graft-Versus-Host Disease. Transplant Cell Ther. 2021 03; 27(3):272.e1-272.e5.
Score: 0.020
-
Low-dose alemtuzumab (Campath) in myeloablative allogeneic stem cell transplantation for CD52-positive malignancies: decreased incidence of acute graft-versus-host-disease with unique pharmacokinetics. Bone Marrow Transplant. 2004 Apr; 33(8):833-7.
Score: 0.006